CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 611547851
- Phone
- (858) 500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- Open-market buys, last 90 days
- $1,239,000
- in 1 filing
- Open-market sales, last 90 days
- $1,708,041
- in 8 filings, $650K under 10b5-1 plans
Net −$469,041. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- WILSON TROY EDWARD +$1.2M President and CEO 1 filing
- Bair Teresa Brophy −$486K Chief Legal Officer sold 18% of stake
- Leoni Mollie −$440K Chief Medical Officer sold 23% of stake
- Powl Brian T. −$397K Chief Commercial Officer sold 21% of stake
- Burrows Francis −$225K Chief Scientific Officer sold 33% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-29 | FORD KATHLEEN Chief Operating Officer | Sale 10b5-1 | −3,668 | $10.75 | $39K | 142,986 |
| 2026-09-29 | Leoni Mollie Chief Medical Officer | Sale | −28,802 | $10.75 | $310K | 141,095 |
| 2026-09-29 | Powl Brian T. Chief Commercial Officer | Sale | −15,430 | $10.75 | $166K | 136,819 |
| 2026-09-28 | Bair Teresa Brophy Chief Legal Officer | Sale 10b5-1 | −8,442 | $10.50 | $89K | 187,002 |
| 2026-09-28 | FORD KATHLEEN Chief Operating Officer | Sale 10b5-1 | −6,906 | $10.50 | $72K | 146,654 |
| 2026-09-28 | Leoni Mollie Chief Medical Officer | Sale | −12,448 | $10.50 | $131K | 169,897 |
| 2026-09-28 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Sale | −4,607 | $10.50 | $48K | 142,428 |
| 2026-09-28 | Powl Brian T. Chief Commercial Officer | Sale | −9,020 | $10.50 | $95K | 160,249 |
| 2026-09-28 | Powl Brian T. Chief Commercial Officer | Sale | −8,000 | $10.56 | $84K | 152,249 |
| 2026-09-24 | Burrows Francis Chief Scientific Officer | Option exercise | +30,000 | $6.15 | $185K | 63,053 |
| 2026-09-24 | Burrows Francis Chief Scientific Officer | Sale | −20,726 | $10.83 | $225K | 42,327 |
| 2026-09-24 | Burrows Francis Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −30,000 | 0 | ||
| 2026-09-08 | Fulk Jennifer Chief Financial Officer | Grant or award · Option to purchase common stock 10b5-1 | +450,000 | 450,000 | ||
| 2026-08-24 | WILSON TROY EDWARD President and CEO | Purchase | +100,000 | $12.39 | $1.2M | 479,194 |
| 2026-08-21 | Powl Brian T. Chief Commercial Officer | Sale 10b5-1 | −4,345 | $11.89 | $52K | 169,269 |
| 2026-08-19 | Bair Teresa Brophy Chief Legal Officer | Sale 10b5-1 | −31,487 | $12.63 | $398K | 195,444 |
| 2026-08-17 | WILSON TROY EDWARD President and CEO | Purchase | +100,000 | $11.12 | $1.1M | 379,194 |
| 2026-06-18 | Leoni Mollie Chief Medical Officer | Sale 10b5-1 | −84,929 | $9.82 | $834K | 182,345 |
| 2026-06-04 | Parks Diane L. Director | Grant or award · Option to purchase common stock | +35,000 | 35,000 | ||
| 2026-06-04 | VASCONCELLES MICHAEL Director | Grant or award · Option to purchase common stock | +35,000 | 35,000 |
Page 1 of 9 · 164 trades